Analysts expect Cytek Biosciences, Inc. to report revenue of 55.04 M for Q3 26, against a range of 53.15 M to 56.93 M. The most recent reported quarter, Q2 26, came in at 48.14 M, a 1.4% miss against the 48.83 M consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 51.50 M | 57.48 M | 41.46 M | 45.60 M | 52.29 M | 62.14 M | 44.13 M | 48.14 M | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 51.69 M | 57.34 M | 47.11 M | 45.98 M | 51.36 M | 63.25 M | 43.70 M | 51.79 M | 56.93 M | 67.39 M | 53.80 M | 58.31 M | 62.55 M | 65.29 M | 57.43 M | 61.79 M | ||||||||||
| Low Estimate | 46.38 M | 53.57 M | 43.29 M | 40.98 M | 44.10 M | 58.71 M | 41.14 M | 45.88 M | 53.15 M | 63.39 M | 49.25 M | 52.27 M | 53.13 M | 60.27 M | 51.61 M | 54.79 M | ||||||||||
| Consensus Estimate | 49.03 M | 55.45 M | 45.20 M | 43.48 M | 47.73 M | 60.98 M | 42.42 M | 48.83 M | 55.04 M | 65.39 M | 51.52 M | 55.29 M | 57.84 M | 62.78 M | 54.52 M | 58.29 M |
Analysts expect Cytek Biosciences, Inc. to report earnings per share of -0.07 for Q3 26, against a range of -0.07 to -0.07. The most recent reported quarter, Q2 26, came in at -0.09 , in line with the -0.09 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 0.06 | 0.12 | -0.09 | -0.04 | 0.00 | -0.34 | -0.15 | -0.09 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 0.01 | 0.11 | -0.03 | -0.05 | -0.03 | -0.02 | -0.09 | -0.09 | -0.07 | -0.02 | -0.11 | -0.07 | -0.06 | -0.09 | -0.07 | -0.03 | ||||||||||
| Low Estimate | 0.01 | 0.09 | -0.03 | -0.05 | -0.03 | -0.02 | -0.09 | -0.09 | -0.07 | -0.02 | -0.11 | -0.09 | -0.08 | -0.09 | -0.07 | -0.03 | ||||||||||
| Consensus Estimate | 0.01 | 0.10 | -0.03 | -0.05 | -0.03 | -0.02 | -0.09 | -0.09 | -0.07 | -0.02 | -0.11 | -0.08 | -0.07 | -0.09 | -0.07 | -0.03 |
Pull Wall Street consensus for Cytek Biosciences, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=CTKB&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "CTKB", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=CTKB&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();